欧美综合自拍亚洲综合网_欧美黑人巨大videos异族_可乐操中文字幕_亚洲成av人福利专区网站_国产强奸视频在播放_免费无码国产在线53_最近最新的免費中文字幕_抖音免费视频素材_亚洲精品熟女一二区_国产无套粉嫩白浆在线麻豆

纖維蛋白原β(FGB)多克隆抗體

Polyclonal Antibody to Fibrinogen Beta Chain (FGB)

FG-B; Fibrinopeptide B; Fibrinogen Beta

  • 纖維蛋白原β(FGB)多克隆抗體 產(chǎn)品包裝(模擬)
  • 纖維蛋白原β(FGB)多克隆抗體 產(chǎn)品包裝(模擬)
  • 纖維蛋白原β(FGB)多克隆抗體 DAB staining on IHC-P; Samples: Rat Kidney Tissue; Primary Ab: 20μg/ml Rabbit Anti-Rat FGb Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • 纖維蛋白原β(FGB)多克隆抗體 DAB staining on IHC-P;
    Sample: Rat Liver Tissue
    Primary Ab: 20μg/ml Rabbit Anti-Rat FGB Antibody
    Control: Used PBS instead of primary antibody
    Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 纖維蛋白原β(FGB)多克隆抗體 DAB staining on IHC-P;
    Samples: Rat Liver Tissue;
    Primary Ab: 20μg/ml Rabbit Anti-Rat FGb Antibody
    Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 纖維蛋白原β(FGB)多克隆抗體 DAB staining on IHC-P;
    Sample: Rat Spleen Tissue;
    Primary Ab: 20ug/ml Rabbit Anti-Rat FGB Antibody
    Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 纖維蛋白原β(FGB)多克隆抗體 DAB staining on IHC-P;
    Sample: Rat Kidney Tissue
    Primary Ab: 20μg/ml Rabbit Anti-Rat FGB Antibody
    Control: Used PBS instead of primary antibody
    Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 纖維蛋白原β(FGB)多克隆抗體 DAB staining on IHC-P;
    Sample: Rat Spleen Tissue
    Primary Ab: 20μg/ml Rabbit Anti-Rat FGB Antibody
    Control: Used PBS instead of primary antibody
    Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • PAB215Ra01.jpg WB圖
  • 纖維蛋白原β(FGB)多克隆抗體 Western Blot; Sample: Rat Liver lysate;
    Primary Ab: 1μg/ml Rabbit Anti-Rat FGb Antibody
    Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 纖維蛋白原β(FGB)多克隆抗體 Western Blot; Sample: Lane1: Rat Serum; Lane2: Rat Mammary gland lysate; Lane3: Rat Spleen lysate
    Primary Ab: 0.02μg/ml Rabbit Anti-Rat FGB Antibody
    Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 纖維蛋白原β(FGB)多克隆抗體 Western Blot; Sample: Human Hela cell lysate;
    Primary Ab: 1μg/ml Rabbit Anti-Rat FGb Antibody
    Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對FGB的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別FGB。

用法

免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學(xué):5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué):5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號 適用物種:Rattus norvegicus (Rat,大鼠) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPB215Ra01 纖維蛋白原β(FGB)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB215Ra02 纖維蛋白原β(FGB)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB215Ra02 纖維蛋白原β(FGB)多克隆抗體 WB; IHC; ICC; IP.
PAB215Ra01 纖維蛋白原β(FGB)多克隆抗體 WB; IHC; ICC; IP.
LAB215Ra71 纖維蛋白原β(FGB)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
LAB215Ra81 纖維蛋白原β(FGB)多克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
MAB215Ra21 纖維蛋白原β(FGB)單克隆抗體 WB; IHC; ICC; IP.
SEB215Ra 纖維蛋白原β(FGB)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB215Ra 纖維蛋白原β(FGB)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.
KSB215Ra01 纖維蛋白原β(FGB)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) 自己動手制作ELISA試劑盒的主要材料

參考文獻(xiàn)

雜志 參考文獻(xiàn)
United States Patent Application Compositions and Methods for Diagnosing Lung Cancer [y2016:0077095.html]
Microbial Pathogenesis Crystal structure of GAPDH of Streptococcus agalactiae and characterization of its interaction with extracellular matrix molecules [Pubmed: 30553015]
GLYCOCONJUGATE JOURNAL Nattokinase-heparin exhibits beneficial efficacy and safety—an optimal strategy for CKD patients on hemodialysis [Pubmed: 30788657]
留言咨詢